The Food and Drug Administration recently issued a “GRAS No Objection Letter” for Parabel USA Inc.’s trademarked Lentein plant protein, according to the ingredient producer.

Parabel CEO Anthony Tiarks said getting a “no objection letter” from FDA goes beyond their strict compliance to industry standards “and reaffirms our company’s values
Continue Reading FDA grants new lentil protein ‘Generally Recognized as Safe’ status